← brief for 2026-08-13 · Slowing decline

The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

Finerenone reduces heart failure risk in patients with CKD and diabetes. The study used data from 3,000 patients over 5 years.

Who did this work

Inciardi RM · Ostrominski JW · Claggett BL · Brinker M · Filippatos G · Lay-Flurrie J · Glasauer A · Scalise A · Rossing P · Ruilope LM · Anker SD · Pitt B

Source

Article · PubMed, the drug frontier · 2026 Aug 10
https://pubmed.ncbi.nlm.nih.gov/42575462/